Breckenridge Pharmaceutical recalls

3 recent recalls on record for Breckenridge Pharmaceutical in CPSC, NHTSA, and FDA data as of July 24, 2026 at 1:09 AM UTC.

Models with recalls

FDA Class II · Drug · June 17, 2026

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit

Official ID D-0583-2026 · Official record ↗

FDA Class II · Drug · June 17, 2026

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit

Official ID D-0582-2026 · Official record ↗

FDA Class II · Drug · May 13, 2026

CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit

Official ID D-0522-2026 · Official record ↗

Verify with the official sources:

Found something wrong or missing? Report a data error.

Compiled from official public-domain government data. Last checked July 24, 2026 at 1:09 AM UTC.